Form 4: Director Acquires Shares and Options in Catheter Precision, Inc.
SEC Form 4 Filing
A director of Catheter Precision, Inc. has acquired shares and stock options, as detailed in a recent SEC filing.
Summary
- Martin J. Colombatto, a director at Catheter Precision, Inc., has reported a transaction involving the company's stock.
- On January 29, 2025, Mr. Colombatto acquired 3 shares of common stock at a price of $0.4002 per share.
- He also acquired 100,000 stock options with an exercise price of $0.42 per share.
- The stock options vest in three tranches: 33.33% on January 29, 2025, 33.33% on January 29, 2026, and 33.34% on January 29, 2027.
- Following these transactions, Mr. Colombatto directly owns 100,000 stock options and indirectly owns 57 shares of common stock through the M Colombatto Trust.
Sentiment
Score: 6
Explanation: The document reflects a routine insider transaction. While the acquisition of shares and options by a director is generally positive, it's not a major event that would significantly impact sentiment.
Positives
- The acquisition of shares and options by a director could be seen as a positive sign of confidence in the company's future.
Industry Context
This filing is a routine disclosure of insider transactions, which is common in publicly traded companies. It provides transparency into the trading activities of company directors.
Comparison to Industry Standards
- Insider transactions are a common occurrence in publicly listed companies, and this filing is consistent with standard reporting practices.
- The vesting schedule of the stock options is typical for executive compensation packages, often designed to align management's interests with long-term company performance.
- The share price and option exercise price are specific to Catheter Precision, Inc. and would need to be compared to similar companies in the medical device industry for a more detailed analysis.
Stakeholder Impact
- The transaction may have a minor positive impact on shareholder sentiment, as it indicates a director's confidence in the company.
Key Dates
| Date | Description |
|---|---|
| 01/29/2025 | Date of the stock and stock option transaction. |
| 01/29/2025 | First vesting date for 33.33% of the stock options. |
| 01/29/2026 | Second vesting date for 33.33% of the stock options. |
| 01/29/2027 | Third vesting date for 33.34% of the stock options. |
| 01/31/2025 | Date the SEC Form 4 was signed. |
| 01/29/2035 | Expiration date of the stock options. |
Keywords
Catheter Precision, Director Transaction, Stock Options, SEC Form 4, Beneficial Ownership, Equity Securities
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.